RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 2023, 15 , 1565.
- Resource Type
- Correction Notice
- Authors
- Wiesinger, Anna-Maria; Bigger, Brian; Giugliani, Roberto; Lampe, Christina; Scarpa, Maurizio; Moser, Tobias; Kampmann, Christoph; Zimmermann, Georg; Lagler, Florian B.
- Source
- Pharmaceutics. Nov2023, Vol. 15 Issue 11, p2596. 2p.
- Subject
- *MUCOPOLYSACCHARIDOSIS
*AUTHORS
- Language
- ISSN
- 1999-4923
The article titled "An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis" has been retracted by the journal Pharmaceutics. The retraction was made due to concerns about the use of unpublished trial data without permission and potential inaccuracies in the data. The investigation confirmed that the authors did not have appropriate permission to use the trial data and that there were errors in the presentation of the data. The authors of the article have agreed to the retraction. [Extracted from the article]